Akebia Therapeutics, Inc.
AKBA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517022
No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Akebia Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 143
- +25 vs. Q4 2024
- Shares held
- 95.5M
- +33.8M (+54.8%) vs. Q4 2024
- Total value
- $182.7M
- +$65.5M (+55.9%) vs. Q4 2024
- New holders
- 30
- 64 more added
- Sold out
- 5
- 25 more reduced
3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AKBA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 170 | $123.2M |
| Q1 2026 | 171 | $141.4M |
| Q4 2025 | 166 | $190.4M |
| Q3 2025 | 177 | $337.7M |
| Q2 2025 | 158 | $394.1M |
| Q1 2025 | 143 | $182.7M |
| Q4 2024 | 121 | $128.9M |
| Q3 2024 | 114 | $78.4M |
| Q2 2024 | 103 | $57.4M |
| Q1 2024 | 114 | $104.3M |
| Q4 2023 | 87 | $72.7M |
| Q3 2023 | 76 | $58.0M |
| Q2 2023 | 79 | $46.0M |
| Q1 2023 | 65 | $29.1M |
| Q4 2022 | 75 | $30.2M |
| Q3 2022 | 90 | $16.5M |
| Q2 2022 | 97 | $20.2M |
| Q1 2022 | 124 | $58.3M |
| Q4 2021 | 133 | $218.7M |
| Q3 2021 | 127 | $283.7M |
| Q2 2021 | 139 | $402.4M |
| Q1 2021 | 145 | $340.3M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Akebia Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rafferty Asset Management, LLC | 206,630 | $396.7K | 0.00% | +26,878+15.0% | Added |
| Diametric Capital, LP | 211,325 | $405.7K | 0.48% | +123,210+139.8% | Added |
| Creative Planning | 229,670 | $441.0K | 0.00% | +63,367+38.1% | Added |
| Mackenzie Financial Corp | 237,558 | $456.1K | 0.00% | +102,166+75.5% | Added |
| Invesco Ltd. | 260,603 | $500.4K | 0.00% | +139,957+116.0% | Added |
| Rhumbline Advisers | 282,066 | $541.6K | 0.00% | +16,677+6.3% | Added |
| Citigroup Inc | 306,000 | $587.5K | 0.00% | +69,214+29.2% | Added |
| Barclays PLC | 308,135 | $591.6K | 0.00% | −67,360−17.9% | Reduced |
| Bank of America Corp | 481,910 | $925.3K | 0.00% | −62,006−11.4% | Reduced |
| Bank of New York Mellon Corp | 493,593 | $947.7K | 0.00% | −3,954−0.8% | Reduced |
| Longaeva Partners L.P. | 500,000 | $960.0K | 0.54% | +500,000 | New |
| Dimensional Fund Advisors LP | 535,431 | $1.03M | 0.00% | +409,751+326.0% | Added |
| UBS Group AG | 592,410 | $1.14M | 0.00% | +241,319+68.7% | Added |
| Charles Schwab Investment Management Inc | 622,914 | $1.20M | 0.00% | +36,204+6.2% | Added |
| AXA S.A. | 627,892 | $1.21M | 0.00% | +627,892 | New |
| Wellington Management Group LLP | 666,567 | $1.28M | 0.00% | +164,440+32.7% | Added |
| Susquehanna International Group, LLP | 687,279 | $1.32M | 0.00% | +101,182+17.3% | Added |
| JPMorgan Chase & Co | 741,161 | $1.42M | 0.00% | +284,867+62.4% | Added |
| FMR LLC | 872,484 | $1.68M | 0.00% | +125,478+16.8% | Added |
| Federated Hermes, Inc. | 913,449 | $1.75M | 0.00% | −554−0.1% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 969,834 | $1.86M | 0.01% | −57,062−5.6% | Reduced |
| Qube Research & Technologies Ltd | 1,068,277 | $2.05M | 0.00% | −123,082−10.3% | Reduced |
| Millennium Management LLC | 1,203,852 | $2.31M | 0.00% | +1,034,205+609.6% | Added |
| Balyasny Asset Management LLC | 1,245,494 | $2.39M | 0.01% | +971,042+353.8% | Added |
| Monashee Investment Management LLC | 1,500,000 | $2.88M | 0.34% | +1,500,000 | New |
| Affinity Asset Advisors, LLC | 1,500,000 | $2.88M | 0.45% | +1,500,000 | New |
| Jacobs Levy Equity Management, Inc | 1,579,355 | $3.03M | 0.01% | +350,645+28.5% | Added |
| Northern Trust Corp | 1,711,191 | $3.29M | 0.00% | +25,550+1.5% | Added |
| EAM Investors, LLC | 1,777,911 | $3.41M | 0.59% | +1,777,911 | New |
| Nantahala Capital Management, LLC | 2,000,000 | $3.84M | 0.32% | +2,000,000 | New |
| Woodline Partners LP | 2,485,578 | $4.77M | 0.03% | +2,485,578 | New |
| Franklin Resources Inc | 2,667,327 | $5.12M | 0.00% | +2,500,143+1,495.4% | Added |
| Morgan Stanley | 2,681,198 | $5.15M | 0.00% | +891,147+49.8% | Added |
| Goldman Sachs Group Inc | 2,724,439 | $5.23M | 0.00% | +1,722,245+171.8% | Added |
| AIGH Capital Management LLC | 2,925,000 | $5.62M | 2.91% | +2,925,000 | New |
| Citadel Advisors LLC | 3,646,909 | $7.00M | 0.01% | +2,264,763+163.9% | Added |
| Renaissance Technologies LLC | 4,005,827 | $7.69M | 0.01% | +182,300+4.8% | Added |
| Great Point Partners LLC | 4,973,840 | $9.55M | 5.19% | +4,973,840 | New |
| Geode Capital Management, LLC | 5,030,740 | $9.66M | 0.00% | +235,645+4.9% | Added |
| State Street Corp | 6,805,807 | $13.1M | 0.00% | +501,109+7.9% | Added |
| Vanguard Group Inc | 12,685,803 | $24.4M | 0.00% | +1,801,603+16.6% | Added |
| BlackRock, Inc. | 15,332,163 | $29.4M | 0.00% | +234,538+1.6% | Added |
| Nuveen, LLC | 350,413 | – | – | +350,413 | New |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −43,360−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −40,826−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −24,998−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −12,903−100.0% | Sold out |
| RB Capital Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Satter Management Co., L.P. | – | – | – | – | Not filed |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| AlphaMark Advisors, LLC | – | – | – | – | Not filed |